April 2, 2024

Life With GLP-1s | It's Time to Reframe Obesity

It’s Time to Reframe Obesity

Download the full white paper to learn more


Clinical and cultural conversations around obesity have long revolved around BMI (and its credibility), harmful stereotypes, issues of equity and the multi-million dollar weight loss industry. Now that GLP-1s have entered the picture as a quick-acting weight loss solution, there’s an argument to be made that we’re getting farther from the root of the problem: weight loss maintenance.